MAR 20, 2018 09:17 PM PDT

Treatment for Post-Surgical Nausea and Vomiting

WRITTEN BY: Nouran Amin
1 2 151

Amisulpride, a drug developed for the treatment of schizophrenia, was studied to be effective in preventing postoperative nausea and vomiting (PONV). The drug was seen to decrease the development of PONV when used in combination with a standard anti-nausea treatment; administered intraoperatively.

"Tens of millions of Americans undergo surgery each year, and many suffer from nausea and vomiting after their operation," says Dr. Kranke, a professor of anesthesiology at the University of Würzburg in Germany."Post-operative nausea and vomiting contribute to patient distress, can delay recovery after surgery and increases hospital costs. Patients with multiple risk factors for PONV require a multimodal approach for its prevention, including using a combination of anti-nausea drugs with different mechanisms of action, since it cannot be predicted which pathway(s) will be active in a patient."

A significant factor associated with the development of PONV has a lot to do with gender; female surgical patients are more likely to be at risk. Other risk factors include a prior history of PONV, being prone to motion sickness, nonsmoking individuals, and those in need of opioids from the surgical-related pain. Not preventing PONV will cause nausea and vomiting to at least 60 to 80 percent of patients who exhibit at minimum three of the known risk factors. The current treatment options that prevent post-surgery nausea and vomiting include classes of corticosteroid and serotonin 5-HT3; which are given intraoperatively. However, this was never enough and an additional drug needed to be developed and administered in combination with previous treatments to maximize efficacy; "safe and effective anti-nausea drugs from other classes are needed to complement these," says Dr. Kranke, a lead researcher of the study.

Furthermore, the mechanism of Amisulpride works physiologically to inhibit dopamine signaling in the body. Comparable dopamine-blocking compounds were examined to prevent and treat post-surgical nausea and vomiting; however, these treatments are now disregarded due to associated side effects involving irregular heartbeats and movement disorders. Therefore, Amisulpride is safe and effective in comparison to the other known drug treatments.

The research study, published in the journal Anesthesiology, examined 1,147 adult patients that were administered general anesthesia and undergoing elective surgery, and who also possess at least three or four of the PONV risk factors. The patients were randomly matched to a type of amisulpride administration and with an additional anti-nausea drug treatment with a placebo. Investigators concluded that high-risk surgical patients receiving a low dose of intravenous Amisulpride in combination an anti-nausea drug (from a different class of compounds) were safe and effective. "This could enable improved control of PONV and allow for earlier mobilization and discharge of surgical patients," Dr. Kranke said.

As of now, the U.S. Food and Drug Administration is reviewing the use of Amisulpride.

Sources: Anesthesiology, Medical Xpress

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
MAR 10, 2018
Drug Discovery
MAR 10, 2018
Treatment Intended for Osteoarthritis, Decreases Opioid Dependence
Treatment intended for osteoarthritis succeeds in decreasing symptoms of an opioid addiction.
MAR 15, 2018
Health & Medicine
MAR 15, 2018
Cannabis compound shows promise for severe epilepsy
For the first time, a form of medicinal cannabis has been shown to reduce—and even stop—seizures in some children with a severe form of epileps
APR 10, 2018
Drug Discovery
APR 10, 2018
Targeting CDK7 in Treatment-Resistant Cancers
Investigators have unveiled a new class of drug that may treat cancer patients who can no longer respond to approved therapeutics. This particular drug may
APR 14, 2018
Drug Discovery
APR 14, 2018
First Hydrocarbon Peptide Therapeutic for Lethal Leukemia
  Acute myeloid leukemia (AML) is a lethal cancer of the blood and bone marrow. It affects a group of white blood cells known as the myeloid cells, wh
JUN 27, 2018
Drug Discovery
JUN 27, 2018
Drug Reduces Hearing Loss in Children Treated for Hepatoblastoma
Children treated for hepatobalstoma, a rare childhood liver cancer, often experience hearing loss when undergoing a type of chemotherapy known as cisplatin
JUL 17, 2018
Videos
JUL 17, 2018
Novartis Ends Antibiotic Research
The United Nations has warned that by 2050, antibiotic-resistant microbes might kill ten million people every year.
Loading Comments...